基本信息
浏览量:9
职业迁徙
个人简介
Dr. Mekalanos has received many honors, including the Eli Lilly Award (1991), AAAS Newcomb Cleveland Prize (1993), the City of Medicine Award (1997) and election to the National Academy of Sciences (1998) and the American Academy of Microbiology (1999). In 2012 he was chosen as the first recipient of the Drexel Medicine Prize in Infectious Disease and he received the Sanofi-Institut Pasteur Award for Biomedical Research. He has been a member of the FDA Advisory Committee on Vaccines and Related Biologics and has consulted for numerous governmental and private agencies including the National Institutes of Health, the World Health Organization, The International Vaccine Institute, the National Academy of Sciences, Massachusetts Public Health Biological Laboratories, and the U.S.-Japan Cooperative Medical Science Program.
His research spans multiple facets of bacterial pathogenesis with an emphasis on using genetic and functional genomic approaches to explore virulence gene regulation and host-pathogen interactions. His laboratory has provided many genetic tools that have been successfully used in the field for decades, establishing fundamentally new approaches to understanding bacterial virulence from the gene to the genomic levels. Most recently his group discovered and characterized the Type 6 Secretion System. This new dynamic intracellular organelle of bacteria is now known to affect cell-cell interactions within the host microbiota, a process that affects the fitness of both pathogenic and commensal microorganisms. His group has also contributed to the development of prototype vaccines effective against cholera, typhoid, anthrax and other microorganisms.
研究兴趣
论文共 209 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Human vaccines & immunotherapeuticsno. 2 (2023): 2262639
biorxiv(2022)
William P. Robins,John J. Mekalanos
biorxiv(2022)
mBiono. 6 (2020)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn